Notch-1 and notch-4 biomarker expression in triple-negative breast cancer

International Journal of Surgical Pathology

Volumn 20, Issue 2, 2012, Pages 139-145

  Speiser, Jodi ^a   Foreman, Kimberly ^a   Drinka, Eva ^a   Godellas, Constantine ^a   Perez, Claudia ^a   Salhadar, Alia ^a   Erşahin, Çaǧatay ^a   Rajan, Prabha ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

breast; carcinoma; Notch 1; Notch 4; pathology; triple negative

Indexed keywords

KI 67 ANTIGEN; NOTCH1 RECEPTOR; NOTCH4 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ILLINOIS; KI-67 ANTIGEN; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RECEPTOR, ERBB-2; RECEPTOR, NOTCH1; RECEPTORS, ESTROGEN; RECEPTORS, NOTCH; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84860175405     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896911427035     Document Type: Article

References (28)

1. Dent R, Trudeau M, Pritchard KI, et al. Triple negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007 ; 13: 4429
2. Lee CW, Simin K, Liu Q, et al. A functional Notch-surviving gene signature in basal breast cancer. Breast Cancer Res. 2008 ; 10: R97
3. Mittal S, Subramanyam D, Dey D, Kumar RV, Rangarajan A. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer. 2009 ; 8: 128
4. Chacon RD, Costanzo MV. Triple negative breast cancer. Breast Cancer Res. 2010 ; 12 (suppl 2). S3
5. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999 ; 284: 770-776 (Pubitemid 29291335)
6. Bray SJ. Notch signaling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006 ; 7: 678-689 (Pubitemid 44268213)
7. Six E, Ndiaye D, Laabi Y, et al. The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and γ-secretase. Proc Natl Acad Sci U S A. 2003 ; 100: 7638-7643 (Pubitemid 36760022)
8. Brennan K, Brown AM. Is there a role for Notch signaling in human breast cancer?. Breast Cancer Res. 2003 ; 5: 69-75 (Pubitemid 36348099)
9. Miele L, Golde T, Osborne B. Notch signaling in cancer. Curr Mol Med. 2006 ; 6: 905-918 (Pubitemid 44883940)
10. Weijzen S, Rizzo P, Braid M, et al. Activation of Notch signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med. 2002 ; 8: 979-986 (Pubitemid 35033702)
11. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signaling requires ligand-induced proteolytic release of intracellular domain. Nature. 1998 ; 393: 382-386 (Pubitemid 28269713)
12. Rizzo P, Miao H, D'Souza G, et al. Cross talk between Notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008 ; 68: 5226-5235
13. Reedijk M, Odorcic S, Chang L, et al. High-level co-expression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005 ; 65: 8530-8537 (Pubitemid 41330622)
14. Dickson BC, Mulligan AM, Zhang H, et al. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod Pathol. 2007 ; 20: 685-693 (Pubitemid 46788875)
15. Siziopikou K, Jang M-S, Miao H, Miele L. Notch signaling in ductal carcinoma in situ of the breast. Breast Cancer Res. 2003 ; 5 (2). 69-75
16. Bouras T, Pal B, Vaillant F, et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell. 2008 ; 3: 429-441
17. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004 ; 6: R605 - R615
18. Lee CW, Raskett CM, Prudovsky I, Altieri DC. Molecular dependence of estrogen receptor-negative breast cancer on a Notch-Survivin signaling axis. Cancer Res. 2008 ; 68: 5273-5281
19. Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene. 2003 ; 22: 6598-6608 (Pubitemid 37372340)
20. Lara-Medina F, Pérez-Sánchez V, Saavedra-Pérez D, et al. Triple negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer. 2011 ; 117: 3658-3669
21. Grudzien P, Lo S, Albain KS, et al. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Res. 2010 ; 30: 3853-3867
22. Reedijk M, Odorcic S, Chang L, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005 ; 65: 8530-8537 (Pubitemid 41330622)
23. Yao K, Rizzo P, Rajan P, et al. Notch-1 and Notch-4 receptors as prognostic markers in breast cancer [published online ahead of print August 1, 2011]. Int J Surg Pathol.:
24. Barten DM, Meredith JE, Zaczek R, Houston JG, Albright CF. Gamma-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity. Drugs R D. 2006 ; 7 (2). 87-97
25. Ademuyiwa FO, Groman A, O'Connor T, Ambrosone C, Watroba N, Edge SB. Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer. 2011 ; 117: 4132-4140
26. Cheung K, Syed BM, Green AR, Morgan DAL, Ellis IO. Clinical outcome of triple-negative primary breast cancer in older women: comparison with their younger counterparts. J Clin Oncol. 2011 1057 ; 29 ( suppl ):
27. Ghosh JC, Dohi T, Raskett CM, Kowalik TF, Altieri DC. Activated checkpoint kinase 2 provides a survival signal for tumor cells. Cancer Res. 2006 ; 66: 11576-11579 (Pubitemid 46094165)
28. O'Connor DS, Wall NR, Porter AC, Altieri DC. A p34 (cdc2) survival checkpoint in cancer. Cancer Cell. 2002 ; 2: 43-54 (Pubitemid 41043987)